CYPHERPUNK TECHNOLOGIES INC. (CYPH) Net Margin
- 2021-12-31: Net Margin -2876.80%.
- 2021-09-30: Net Margin -2970.40%.
- 2021-06-30: Net Margin -2540.27%.
- 2021-03-31: Net Margin -2435.73%.
Complete source-backed net margin history.
- Available history
- 2020-03-31 to 2021-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2021-12-31 | -2876.80% |
| 2021-09-30 | -2970.40% |
| 2021-06-30 | -2540.27% |
| 2021-03-31 | -2435.73% |
| 2020-12-31 | -1789.33% |
| 2020-09-30 | -1881.87% |
| 2020-06-30 | -1737.60% |
| 2020-03-31 | -1928.27% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2021-12-31 | -2705.80% |
| 2020-12-31 | -1834.27% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |